ANGPTL6 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8NI99 |
---|---|
Other Accession | NP_114123 |
Clone Names | 71211107 |
Gene ID | 83854 |
---|---|
Other Names | Angiopoietin-related protein 6, Angiopoietin-like protein 6, Angiopoietin-related growth factor, Angiopoietin-related protein 5, ANGPTL6, AGF, ARP5 |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP7769b was selected from the C-term region of human ANGPTL6. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | ANGPTL6 |
---|---|
Synonyms | AGF, ARP5 |
Function | May play a role in the wound healing process. May promote epidermal proliferation, remodeling and regeneration. May promote the chemotactic activity of endothelial cells and induce neovascularization. May counteract high-fat diet-induced obesity and related insulin resistance through increased energy expenditure. |
Cellular Location | Secreted. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
ANGPTL6 may play a role in the wound healing process. It may promote epidermal proliferation, remodeling and regeneration and may promote the chemotactic activity of endothelial cells and induce neovascularization. ANGPTL6 may counteract high-fat diet-induced obesity and related insulin resistance through increased energy expenditure.
References
Zhang,Y., Biochem. Biophys. Res. Commun. 347 (1), 100-108 (2006)Oike,Y., Blood 103 (10), 3760-3765 (2004)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.